Results 71 to 80 of about 64,981 (166)

Antibodies to watch in 2026. [PDF]

MAbs
Crescioli S, Kaplon H, Chenoweth A, Hsu YS, Pinto K, Kapoor V, Reichert JM.   +6 more
europepmc   +1 more source

Strain-specific propagation of variant Creutzfeldt-Jakob disease prions in humanized neural cells. [PDF]

Proc Natl Acad Sci U S A
Rayner MLD, Arora P, Linehan JM, Ros H, Nihat A, Argentina F, Preston C, Schmidt C, Ribes JM, Klöhn PC, Mead S, Brandner S, Collinge J, Jat PS.   +13 more
europepmc   +1 more source

Immunotherapy of diffuse large B-cell lymphoma: from monoclonal antibodies to cellular therapies. A narrative review. [PDF]

Front Immunol
Aureli A, Lanzilli G, Boccadamo Pompili SV, Spagnoli GC, Sconocchia G, Caratelli S.   +5 more
europepmc   +1 more source

A comprehensive evaluation of the human Tg32 and Tg276 FcRn transgenic mouse and non-human primate models for predicting antibody pharmacokinetics in human. [PDF]

MAbs
Gajewska M, Kiffe M, Calonder C, Engelhardt V, Pou I Miralbell C, Gonzalo-Gil E, Christianson G, Bethur N, Flora A.   +8 more
europepmc   +1 more source

A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]

Theranostics
Kim RK, Heo CK, Choi MJ, Kahm YJ, Kim MK, Lee M, Lee JY, Park H, Jung U, Shin BC, Kim BJ, Kim SC, Cho EW, Ryu CJ, Kim IG.   +14 more
europepmc   +1 more source

DNA origami-based virus-like particles: a new class of HIV vaccine candidates with superior immunogenic properties. [PDF]

Signal Transduct Target Ther
Muecksch F, Hamdan J, Fackler OT.
europepmc   +1 more source

A side-by-side biophysical comparison of five single-domain antibody scaffolds used for synthetic display libraries. [PDF]

J Biol Chem
Rauschmayer M, Abdellatif M, Chubanova A, Leonardi N, Preinsberger AB, Schwach J, Stengl A.   +6 more
europepmc   +1 more source

The SIRP family: from structural diversity and signaling mechanisms to implications in immune-related disease targeted therapeutics. [PDF]

Front Immunol
Jin Y, Huang Q, Song J, Abideen ZU, Tan R, Xu S, Chen M.   +6 more
europepmc   +1 more source

Antibody targeting of the TNF-TNFR2 axis to overcome tumor immune resistance. [PDF]

Front Immunol
Kang X, Tong X, Wang S.
europepmc   +1 more source

Candidozyma auris-infected Galleria mellonella larvae: the effect of the humanized monoclonal antibody Dia-T51 and its synergy with amphotericin B. [PDF]

NPJ Antimicrob Resist
Vanzolini T, Fiori V, Magnani M.
europepmc   +1 more source